Boeing Company
BA
$0.00
+0.43%
Boeing is a major aerospace and defense firm operating in commercial airplanes, defense, space, and global services. It is a dominant player in its industry, competing directly with Airbus in commercial aviation and with major defense contractors.
BA
Boeing Company
$0.00
Related headlines
Investment Opinion: Should I buy BA Today?
Based on a synthesis of the data, Boeing warrants a Hold rating for most investors. The overwhelming positive analyst sentiment and potential for a multi-year commercial aerospace recovery provide a compelling long-term narrative. However, the extreme financial leverage, lack of consistent cash flow generation, and high valuation multiples create substantial near-term risk. The stock is suitable only for investors with a high risk tolerance, a long time horizon, and the conviction that management can successfully navigate its operational and balance sheet challenges. It is not recommended for conservative portfolios seeking stability or income.
Sign up to view all
BA 12-Month Price Forecast
The analysis is neutral due to opposing forces: compelling long-term prospects are muddied by severe near-term financial and operational risks. Confidence is medium as the path hinges on management execution, which has been inconsistent.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Boeing Company's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
8 analysts
Implied Upside
—
vs. current price
Analyst Count
8
covering this stock
Price Range
$0 - $0
Analyst target range
A consensus of 15 analysts provides estimates for Boeing. The average estimated EPS is $12.28, with a range from $11.31 to $13.62. Average estimated revenue is $137.45 billion. Recent institutional ratings from firms like Jefferies, UBS, Citigroup, and JP Morgan are overwhelmingly positive, with actions such as 'Buy', 'Overweight', and 'Outperform'.
Bulls vs Bears: BA Investment Factors
Boeing presents a classic high-risk, high-reward investment case. Bullish drivers include a strong revenue recovery, dominant industry position, and supportive defense spending. However, these are counterbalanced by severe bearish factors including crippling debt, inconsistent profitability, and significant operational execution risks. The stock's fate hinges on its ability to translate top-line growth into sustained profits and cash flow.
Bullish
- Strong Q4 Revenue Growth: Q4 2025 revenue grew 57.1% YoY to $23.95B, showing operational recovery.
- Dominant Market Position: Leading player in aerospace & defense with Airbus and major defense contractors.
- Positive Analyst Sentiment: Overwhelmingly positive institutional ratings (Buy, Overweight) from major firms.
- Defense Spending Tailwinds: Geopolitical tensions and commitments to increase advanced weaponry production.
Bearish
- Severe Profitability Issues: Inconsistent earnings, negative operating margin (-6.05%), and thin net margin (2.5%).
- Extremely High Debt Load: Debt-to-equity ratio of 9.98 indicates unsustainable financial leverage.
- Negative Free Cash Flow: Trailing twelve-month FCF is -$1.88B, straining liquidity and investment.
- Operational & Reputational Risks: Starliner program suspension and volatile quarterly results create uncertainty.
BA Technical Analysis
Overall Assessment: The stock has experienced significant volatility over the past six months, declining 8.46% from October 2025 to March 2026. The price peaked near $254 in January 2026 before a sharp correction, indicating a bearish trend reversal from the highs.
Short-term Performance: The stock is down 12.53% over the past month, significantly underperforming the S&P 500's -5.25% return. Over the last three months, it is down 8.33%, also underperforming the broader market's -4.63% decline. The recent price action shows a steep decline from the $250 area in late January to the $190-$200 range in late March.
Current Position: The current price of $199.03 is near the lower end of its 52-week range of $128.88 to $254.35, representing approximately 21.7% above the 52-week low. No RSI data was provided for further momentum analysis.
Beta
1.13
1.13x market volatility
Max Drawdown
-25.2%
Largest decline past year
52-Week Range
$129-$254
Price range past year
Annual Return
+23.5%
Cumulative gain past year
| Period | BA Return | S&P 500 |
|---|---|---|
| 1m | -7.1% | -4.3% |
| 3m | -8.6% | -4.0% |
| 6m | -3.7% | -2.0% |
| 1y | +23.5% | +22.2% |
| ytd | -8.6% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BA Fundamental Analysis
Revenue & Profitability: Quarterly revenue for Q4 2025 was $23.95 billion, showing strong year-over-year growth of 57.11%. However, profitability remains inconsistent; while Q4 2025 showed a net income of $8.22 billion, the preceding Q3 2025 had a net loss of -$5.34 billion. The trailing twelve-month net margin is a thin 2.5%, and the operating margin is negative at -6.05%.
Financial Health: The company's financial health is strained by high leverage, with a debt-to-equity ratio of 9.98, indicating significant reliance on debt financing. Cash flow is also a concern, with free cash flow over the trailing twelve months reported at -$1.88 billion, and quarterly operating cash flow has been volatile, turning positive in Q4 2025 at $1.33 billion.
Operational Efficiency: Return on Equity (ROE) is reported at a high 40.98%, but this is likely distorted by a very low equity base due to the high debt load. Return on Assets (ROA) is negative at -2.0%, indicating inefficient use of assets to generate profit. The current ratio of 1.19 suggests adequate, but not strong, short-term liquidity.
Quarterly Revenue
$23.9B
2025-12
Revenue YoY Growth
+0.57%
YoY Comparison
Gross Margin
+0.07%
Latest Quarter
Free Cash Flow
$-1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BA Overvalued?
Valuation Level: Given the company's inconsistent profitability, we use the Price-to-Sales (PS) ratio as a primary valuation metric. The current PS ratio is 1.85. The forward P/E ratio is 42.37, which is high and reflects expectations for future earnings recovery, while the trailing P/E of 74.05 is elevated due to low recent earnings.
Peer Comparison: Data not available for direct industry average comparisons. The EV/EBITDA of 28.40 and EV/Sales of 2.06 suggest the market is pricing in expectations for improved future cash flows and margins, despite current operational challenges.
PE
74.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -1629x~106x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.4x
Enterprise Value Multiple
Investment Risk Disclosure
Boeing's risk profile is elevated, stemming from financial, operational, and market sources. Financially, the company is highly leveraged with a debt-to-equity ratio near 10, and negative free cash flow limits its ability to service this debt without further borrowing or asset sales. The inconsistent profitability, evidenced by quarterly swings between large profits and losses, and a negative operating margin, indicate fundamental operational instability.
Operational and reputational risks are significant, as highlighted by the indefinite suspension of crewed Starliner flights following a scathing NASA report, jeopardizing over $1 billion in contract revenue. Furthermore, the company faces execution risk in ramping up commercial airplane production to meet demand while managing supply chain and quality issues. Externally, Boeing is exposed to cyclical downturns in air travel, spikes in input costs (e.g., oil prices), and intensifying competition in both commercial aviation and the emerging private space station market.
Market-related risks include the stock's high volatility (beta of 1.1) and its valuation, which embeds a steep recovery narrative. The forward P/E of 42.4 and EV/EBITDA of 28.4 leave little room for error, meaning any stumble in the expected earnings rebound could lead to severe multiple contraction and share price depreciation.
FAQ
The key risks are financial, operational, and executional. Financially, the extreme debt load (D/E 9.98) and negative free cash flow (-$1.88B TTM) are major concerns. Operationally, profitability is volatile (negative operating margin) and programs like Starliner face suspensions. Execution risk is high, as the stock's elevated valuation multiples demand a flawless turnaround in production and cash flow generation.
The 12-month outlook is mixed with a base case target of $210-$240. This assumes gradual progress towards analyst EPS estimates (avg $12.28). A bull case ($254-$280) requires flawless execution, while a bear case ($129-$180) involves operational setbacks. The AI assessment is neutral, assigning a 50% probability to the base case, 30% to the bull case, and 20% to the bear case, reflecting high uncertainty.
BA appears fully valued to slightly overvalued based on current fundamentals. The forward P/E of 42.4 and EV/EBITDA of 28.4 are high, pricing in a significant earnings recovery. The Price-to-Sales ratio of 1.85 is more reasonable but still reflects optimism. The valuation is not cheap given the company's negative free cash flow and high leverage, leaving little margin for error.
BA is a speculative buy, suitable only for high-risk tolerance investors. While analyst sentiment is positive (average EPS estimate $12.28) and the company holds a dominant market position, it is burdened by a debt-to-equity ratio of 9.98 and inconsistent profitability. A purchase is a bet on a successful multi-year operational and financial turnaround that is not yet assured.
BA is strictly a long-term investment (3-5+ years). The company's challenges—massive debt, operational turnaround—will take years to resolve. Short-term price action is likely to remain highly volatile and driven by quarterly execution news and macroeconomic factors. Investors without the patience to weather significant volatility should avoid this stock.